MapLight Therapeutics Statistics

NASDAQ: MPLTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

8.83-0.32 (-3.50%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

MapLight Therapeutics by the numbers

MapLight Therapeutics has a market capitalization of $490.7 million based on 52.85M shares outstanding. With trailing EPS of $-6.03, MapLight Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.2% below its 50-day average and 58.5% below its 200-day average.

Average daily trading volume is 851.70K shares, or about $7.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MPLT valuation vs. peer median

MPLT compared with the median of 8 peer companies
Metric	MPLT	Peer median	Difference
Market cap	$490.73M	$498.16M	-1%
Avg. volume	851.70K	846.58K	+1%

Peer median across 8 companies: ARVN, OVID, ASMB, CTNM, ALT, RZLT, EOLS, OCS.

Valuation

Market cap: $490.73M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-6.03
Shares outstanding: 52.85M

Price and trading

Previous close: 9.15
Open: 9.15
Day range: 8.71 – 9.42
52-week range: 8.71 – 40.43
50-day moving average: 11.81
200-day moving average: 21.29
Beta: —
Volume: 495.35K
Average volume: 851.70K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 12, 2026

Additional statistics

Market Cap: 490.73M
Forward Pe: -2.58
Eps: -6.03
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 40.43
Week52 Low: 8.71
Avg Volume: 851.70K
Shares Outstanding: 52.85M
Ma50: 11.81
Ma200: 21.29
Earnings Date: Nov 12, 2026
Pct From52w High: -78.16%
Pct From52w Low: 1.38%